Literature DB >> 10375295

Alendronate increased bone mineral density but did not reduce new fractures in glucocorticoid induced osteoporosis.

J E Compston1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10375295      PMCID： PMC1727544          DOI： 10.1136/gut.44.6.780

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  4 in total

1.  Randomized trial of effect of cyclical etidronate in the prevention of corticosteroid-induced bone loss. Ciblos Study Group.

Authors:  C Roux; P Oriente; R Laan; R A Hughes; J Ittner; S Goemaere; O Di Munno; J M Pouillès; S Horlait; B Cortet
Journal:  J Clin Endocrinol Metab       Date:  1998-04       Impact factor: 5.958

2.  Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. Glucocorticoid-Induced Osteoporosis Intervention Study Group.

Authors:  K G Saag; R Emkey; T J Schnitzer; J P Brown; F Hawkins; S Goemaere; G Thamsborg; U A Liberman; P D Delmas; M P Malice; M Czachur; A G Daifotis
Journal:  N Engl J Med       Date:  1998-07-30       Impact factor: 91.245

3.  Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis.

Authors:  J D Adachi; W G Bensen; J Brown; D Hanley; A Hodsman; R Josse; D L Kendler; B Lentle; W Olszynski; L G Ste-Marie; A Tenenhouse; A A Chines
Journal:  N Engl J Med       Date:  1997-08-07       Impact factor: 91.245

Review 4.  Esophagitis associated with the use of alendronate.

Authors:  P C de Groen; D F Lubbe; L J Hirsch; A Daifotis; W Stephenson; D Freedholm; S Pryor-Tillotson; M J Seleznick; H Pinkas; K K Wang
Journal:  N Engl J Med       Date:  1996-10-03       Impact factor: 91.245
  4 in total
  1 in total

Review 1.  Effects of alendronate for treatment of glucocorticoid-induced osteoporosis: A meta-analysis of randomized controlled trials.

Authors:  Ya-Kang Wang; Yu-Min Zhang; Si-Qing Qin; Xu Wang; Tao Ma; Jian-Bin Guo; Chao Zhu; Zhuo-Jing Luo
Journal:  Medicine (Baltimore)       Date:  2018-10       Impact factor: 1.817
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.